Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC lowered its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 1.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,237,972 shares of the company’s stock after selling 42,022 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned approximately 4.90% of Azenta worth $111,899,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in AZTA. Dimensional Fund Advisors LP increased its position in shares of Azenta by 0.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company’s stock worth $151,659,000 after purchasing an additional 26,929 shares during the last quarter. Conestoga Capital Advisors LLC increased its holdings in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock valued at $78,894,000 after buying an additional 621,830 shares during the last quarter. Schroder Investment Management Group increased its holdings in Azenta by 46.7% in the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company’s stock valued at $70,183,000 after buying an additional 447,292 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in Azenta by 1.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company’s stock valued at $65,922,000 after buying an additional 18,529 shares in the last quarter. Finally, Federated Hermes Inc. lifted its holdings in Azenta by 65.9% during the 4th quarter. Federated Hermes Inc. now owns 762,189 shares of the company’s stock worth $38,109,000 after buying an additional 302,786 shares during the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on AZTA shares. Stephens reiterated an “overweight” rating and issued a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI boosted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC lifted their price target on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th.

Azenta Price Performance

NASDAQ:AZTA opened at $25.25 on Friday. The firm has a market capitalization of $1.15 billion, a P/E ratio of -8.47 and a beta of 1.66. The business has a 50 day simple moving average of $36.94 and a 200 day simple moving average of $43.97. Azenta, Inc. has a 12-month low of $24.68 and a 12-month high of $63.58.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.